Abstract
ROLE OF SERUM FATTY ACID BINDING PROTEIN (FABP) AND HIGH SENSITIVE CARDIAC TROPONIN (HS-CTN) IN DIAGNOSIS AND DIFFERENTIATION OF ACUTE CORONARY SYNDROME

Bashar J. Hussein*, Basil O. Saleh and Nazar N Abbas

ABSTRACT

Background: Acute coronary syndrome (ACS) refers to any group of clinical symptoms compatible with acute myocardial ischemia including unstable angina, Non-ST-segment elevation myocardial infarction & ST-segment elevation myocardial infarction. Heart – type fatty acid binding protein (H-FABP) also known as mammary-derived growth inhibitor is a protein that in humans is encoded by the FABP3 gene, The diagnostic potential of the biomarker H-FABP for heart injury. Patients, Material & Methods: The present study was conducted at the Department of Biochemistry, College of Medicine/ University of Baghdad during the period from December 2017 until August 2018. Thirty three patients with ACS were included as 11 with unstable angina (UA), 11 with non ST elevation myocardial infarction (NSTEMI), & 11 ST elevation myocardial infarction (STEMI) patients. Also this study included 18 non-ischemic chest pain subjects who served as pathological control. Blood samples were obtained for measurements of FABP and hs-cTn by ELISA method. Results: The mean (±SD) value of FABP was significantly increased in NSTEMI (3.80 ± 1.45ng/ml, p< 0.001) and UA (3.62 ± 0.42 ng/ml, p < 0.001) compared to that of STEMI (1.88 ± 1.60 ng/ml). Also, the mean value of serum H-FABP levels of pathological controls (3.17 ± 0.73 ng/ml) was significantly higher than that of STEMI group (p < 0.001). Regarding hs-cTn, it did not differ significantly among the groups of UA (2.82 ± 0.69), NSTMI (4.08 ± 2.35), and STMI (4.53 ± 2.06). Conclusion: FABP showed significant elevation in UA and NSTMI and may be used as a biochemical marker in assessment of these two conditions and to differentiate them from STEMI.

Keywords: Acute Coronary Syndrome, FABP, hs-cTn.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT